Topical Antimicrobial Strategies in Wound Care

Summary

Topical antimicrobial strategies in wound care combine traditional antiseptics, targeted antibiotics and advanced delivery systems to prevent infection and support tissue regeneration. Despite the efficacy of broad-spectrum agents such as povidone-iodine, chlorhexidine and silver, concerns about cytotoxicity, biofilm persistence and antimicrobial resistance have driven innovation. Modern formulations incorporate polymers, nanoparticles and biocompatible hydrogels to achieve controlled release, reduce host-cell damage and sustain therapeutic concentrations at the wound bed. These multifunctional dressings often integrate haemostatic and anti-inflammatory properties, promoting granulation tissue formation, neovascularisation and re-epithelialisation. Precision dosing of topical antibiotics addresses common pathogens such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus, while stimuli-responsive materials enable on-demand drug delivery in response to pH or enzymatic changes. Collectively, these advances highlight a holistic approach that synchronises microbial clearance with the biological phases of wound repair, offering scalable solutions for diverse clinical settings worldwide.

Research from Nature Portfolio

Recent studies have elucidated how low-concentration povidone-iodine accelerates acute wound healing by modulating key growth factors and cellular responses. Topical application of 0.5 % povidone-iodine in animal models enhanced expression of transforming growth factor β and α-smooth muscle actin, driving robust granulation tissue formation, neovascularisation and re-epithelialisation. Concurrent reduction of pro-inflammatory cytokines such as interleukin-6 further mitigated oedema and pain. Inhibition of the transforming growth factor β pathway abolished these benefits, confirming its central role. These findings establish a mechanistic basis for the dual antimicrobial and regenerative actions of povidone-iodine formulations in skin wound management.

Topical Antimicrobial Strategies in Wound Care publication trend

The graph below shows the total number of articles in topical antimicrobial strategies in wound care across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A structured community of microorganisms embedded in a self-produced extracellular matrix, often resistant to antimicrobials.

Neovascularisation: Formation of new blood vessels within healing tissue to supply oxygen and nutrients.

Re-epithelialisation: Restoration of the epidermal layer by migration and proliferation of keratinocytes at the wound edge.

Granulation tissue: Newly formed connective tissue and microscopic blood vessels that form on the surface of a wound during healing.

Antimicrobial iodophors: Complexes of iodine with water-soluble polymers designed for sustained release of active iodine species.

References

  1. Advances in antimicrobial polymeric iodophors. European Polymer Journal (2023).
  2. Antibiotics against Pseudomonas aeruginosa on Human Skin Cell Lines: Determination of the Highest Non-Cytotoxic Concentrations with Antibiofilm Capacity for Wound Healing Strategies. Pharmaceutics (2024).
  3. Antiseptic, Hemostatic, and Wound Activity of Poly(vinylpyrrolidone)-Iodine Gel with Trimethyl Chitosan. International Journal of Molecular Sciences (2024).
  4. Transforming growth factor β plays an important role in enhancing wound healing by topical application of Povidone-iodine. Scientific Reports (2017).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.